http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110331142-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-154 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 |
| filingDate | 2019-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-110331142-B |
| titleOfInvention | Multi-gene combined detection reagent |
| abstract | The invention belongs to the field of biological medicines, and particularly relates to a tumor marker, a methylation detection reagent, a kit and application thereof. The invention discovers that: colorectal cancer samples can be well distinguished from fecal samples by detecting the methylation level of SDC2, COL4A1/COL4A2 and ITGA4 gene combination promoter regions. The invention utilizes methylation reagent methylation detection reagent containing the gene combination to detect colorectal cancer, and has very high detection sensitivity and specificity on the colorectal cancer, and the detection sensitivity and specificity can reach more than 90 percent. |
| priorityDate | 2019-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 101.